Table 1.
Description of included studies and study sampling methods
Country | Region(s)/Cities | Study | Age Range | Sampling Frame | Sample Selection | Response (%) | Representativenessb |
---|---|---|---|---|---|---|---|
Finland | All | FINRISK | 25–74 | Population register | Age and sex stratified sample | 70 | Yes |
France | Bordeaux, Dijon and Montpellier | Three City | 65+ | Electoral rolls | Random sample of noninstitutionalized individuals | 37 | Yes |
Lille, Bas-Rhin and Haute-Garonne | MONALISA | 35–74 | Electoral rolls | Age and sex stratified random sample | 51 | Yes | |
Germany | South | ActiFE | 65–91 | Population register | Age and sex stratified random sample of noninstitutionalized individuals | 20 | Yes |
Southwest | ESTHER | 50–74 | General practitioners lists | Recruitment during biannually health examination for older adults | Not given | Yesc | |
Northeast | SHIP | 20–79 | Population registers | Two stages: | 69 | Yes | |
(1) Stratification based on N. of residents per municipality | |||||||
(2) Age and sex stratified random sample selection per community | |||||||
Ireland | All | SLAN | 45+ | Postal residential lists | Age and urban/rural location and social class stratified sample | 66 | Yesd |
Italy | Northeast | INCIPE | 40+ | General practitioners lists | Random selection of participants from 62 random selected practices | 62 | Yes |
Central | MATISS | 20–79 | Electoral rolls | Age and sex stratified random sample of four municipalities | 60 | Yes | |
South | VIP | 25–74 | Electoral rolls | Age and sex stratified random sample | 72 | Yes | |
Netherlands | North | LifeLines | 20+ | General practitioners lists | Two stages: | Not given | Yes |
(1) All subjects aged 25–50 years registered with general practitionera | |||||||
(2) Family members of first sample | |||||||
Groningen | PREVEND | 28–75 | Population register | Three stages: | 48 | Yes | |
(1) All inhabitants of city | |||||||
(2) Selection of subjects based on albuminuria level | |||||||
(3) Correction for oversampling of albuminuria | |||||||
Norway | Central | HUNT | 20+ | Census data | All residents in region | 71 | Yes |
Poland | All | PolSenior | 65+ | Population register | Three stages: | 42 | Yes |
(1) Stratification based on N. of residents per municipality | |||||||
(2) Stratification based on streets/towns | |||||||
(3) Age stratified random sample | |||||||
Portugal | All | PREVADIAB | 20–79 | Universal health card (held by 99% of population) | Two stages: | 84 | Yesd |
(1) Age and sex stratified sample | |||||||
(2) Correction for unintentional oversampling of elderly females | |||||||
Spain | All | EPIRCE | 20+ | Census data | Age and sex and habitat stratified random sample | 43 | Yes |
Sweden | Uppsala | PIVUS | 70–70 | Population register | Random selection of all (70-year-old) residents | 50 | n/a |
Switzerland | Southwest | Bus Santé | 35–74 | Population register | Age and sex stratified sample | 62 | Yese |
UK | All | MRC | 75+ | General practitioners lists | Patients registered in a representative sample of general practices | 73 | Yes |
Study acronyms: FINRISK, Finland Cardiovascular Risk Study; MONALISA, MOnitoring NAtionaL du rISque Arteriel; ActiFE Ulm, Activity and Function in the Elderly in Ulm study; ESTHER, Epidemiologische Studie zu Chancen der Verhütung, Früherkennung und optimierten THerapie chronische ERkrankungen in der älteren Bevolkerung; SHIP, Study of Health in Pomeranzia; SLAN, Survey of Lifestyle and Attitudes & Nutrition in Ireland; INCIPE, Initiative on Nephropathy, of relevance to public health, which is Chronic, possibly in its Initial stages, and carries a Potential risk of major clinical Endpoints; MATISS, Malattie cardiovascolari ATerosclerotiche Istituto Superiore di Sanita; VIP, Valle dell’Irno Prevenzione; LifeLines, LifeLines Cohort and Study Biobank; PREVEND, Prevention of Renal and Vascular End-stage Disease; HUNT, Nord-Trøndelag Health Study; PolSenior, Medical, psychologic, sociological and economical aspects of aging of people in Poland; PREVADIAB, Prevalence of Diabetes and Risk Factors in Portugal; EPIRCE, Estudio Epidemiológico de la Insuficiencia Renal en España; PIVUS, Prospective Investigation of the Vasculature in Uppsala Seniors Study; MRC, Medical Research Council trial of assessment and management of older people in the community.
LifeLines additionally included participants which actively volunteered to participate; however, the vast majority of the LifeLines cohort presented in this paper was recruited through their general practitioner.
Representative = age and sex distribution of the study sample is nonsignificantly different from regional/national age and sex distribution.
Under sampling of males in age group 55–59 years, the remaining age ranges were nonsignificantly different from Saarland population of 2000.
After the study population was weighted to census data, there was no significant difference.
Under sampling of age group 35–39 years, the remaining age ranges were nonsignificantly different from the Geneva population of 2005.